← Leaderboards
John J Bissler
Children'S Hospital Med Ctr (Cincinnati)
$1,871,528
Attributed
$1,871,528
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $271.9K · FY2005–16$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,871,528 · 9
By mechanism
R01$1,173,070 · 1
R21$548,518 · 1
M01$139,940 · 6
R13$10,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Tuberous Sclerosis”
- Elizabeth P Henske · Brigham And Women'S Hospital$23,271,457
- David J. Kwiatkowski · Brigham And Women'S Hospital$16,276,792
- Vera P Krymskaya · University Of Pennsylvania$15,930,472
- Brendan D. Manning · Harvard School Of Public Health$14,104,920
- Mustafa None Sahin · Children'S Hospital Boston$12,977,961
- Darcy Krueger · Boston Children'S Hospital$10,517,407
Research focus
Tuberous SclerosisLymphangioleiomyomatosisResearch PersonnelUnited States National Institutes Of HealthGene MutationGenesTissuesClinical ResearchKidneyFundingProteinsMagnetic Resonance ImagingSirolimusAngiomyolipomaMutationMonitorNucleic Acid Repetitive SequenceLaboratory MouseCell GrowthDrug Screening /EvaluationCell LineInstitutionLoss Of HeterozygosityComputer Retrieval Of Information On Scientific Projects Database
Grant awards (15)
Pediatric Nephrology Tribute to Russell Chesney, M.D.$10,000
R13 · FY2016 · DK · contact PI
CLINICAL TRIAL: RAD001 THERAPY OF ANGIOMYOLIPOMATA IN PATIENTS WITH TSC$520
M01 · FY2008 · RR · contact PI
DNA Replication Fork: Pausing, Recombination and Disease$205,802
R01 · FY2007 · DK · contact PI
RAD001 THERAPY OF ANGIOMYOLIPOMATA IN PATIENTS WITH TSC$18,942
M01 · FY2007 · RR · contact PI
RAPAMYCIN THERAPY OF RENAL ANGIOMYOLIPOMAS$10,028
M01 · FY2007 · RR · contact PI
DNA Replication Fork: Pausing, Recombination and Disease$214,369
R01 · FY2006 · DK · contact PI
RAPAMYCIN THERAPY OF RENAL ANGIOMYOLIPOMAS$38,987
M01 · FY2006 · RR · contact PI
RAD001 THERAPY OF ANGIOMYOLIPOMATA IN PATIENTS WITH TSC$5,316
M01 · FY2006 · RR · contact PI
DNA Replication Fork: Pausing, Recombination and Disease$222,090
R01 · FY2005 · DK
RAPAMYCIN THERAPY OF RENAL ANGIOMYOLIPOMAS$49,792
M01 · FY2005 · RR
Utility of Rapamycin for the Treatment of Renal Angiomy*$274,259
R21 · FY2004 · CA
DNA Replication Fork: Pausing, Recombination and Disease$224,467
R01 · FY2004 · DK
Rapamycin Therapy of Renal Angiomyolipomas$16,355
M01 · FY2004 · RR
DNA Replication Fork: Pausing, Recombination and Disease$306,342
R01 · FY2003 · DK
Rapamycin for the Treatment of Renal Angiomyolipomas$274,259
R21 · FY2003 · CA